Fifth vaccine set to enter Phase III clinical trials
A fifth COVID-19 vaccine is scheduled to enter a Phase III clinical trial in the coming weeks with 30,000 participants in the United States and Mexico. Read More »
CDC releases COVID-19 guidance for those with health conditions
The Centers for Disease Control and Prevention (CDC) said those with preexisting health conditions are more at risk of severe illness if they contract COVID-19. Read More »
Alerts Sign-up